Gastrointestinal Carcinoid Tumors
Gastrointestinal carcinoid tumors form in the lining of the GI tract, which includes the stomach, small intestine, colon and rectum.
According to the American Cancer Society, approximately 8,000 cases of gastrointestinal carcinoid tumors are diagnosed each year in the United States.
City of Hope physicians are committed to finding and treating gastrointestinal carcinoid tumors in the earliest stages. Our team of internationally trained gastric specialists uses their clinical expertise and leading-edge technology to provide you with the most accurate diagnosis and effective treatment.
City of Hope’s approach to treating gastrointestinal carcinoid tumors starts with a coordinated, multidisciplinary care team whose primary goals are helping you live a long, healthy life free from cancer. Your care team will discuss a plan that may involve a combination of GI carcinoid tumor treatments, including surgery, chemotherapy and radiation.
By collaborating with other departments and cancer centers, City of Hope has developed an extensive and active portfolio of gastrointestinal carcinoid cancer clinical trials studying new treatments, including more effective surgery, radiation and drug therapy regimens. Many of these promising therapies are only available to City of Hope patients.
Getting treated for gastrointestinal carcinoid tumors at City of Hope means you are steps away from labs where our researchers develop new treatments every day.
When you come to City of Hope, you automatically gain access to an unparalleled array of support services to help you and your family cope with each challenge in your gastrointestinal carcinoid tumor diagnosis and treatment.
Our Gastrointestinal Carcinoid Tumors Program Highlights:
- Minimally invasive procedures, including laparoscopic and robotic surgery that result in less pain and quicker recovery
- Advanced endoscopic procedures for early-stage disease, including endoscopic mucosal resection and endoscopic submucosal dissection
- Genetic testing and customized drug therapy tailored to the molecular profile of GI carcinoid tumors
- Clinical trials, including combining immunotherapy with radiation therapy, to bolster the immune system response to fighting cancer
- Palliative procedures designed to improve quality of life
City of Hope’s team of surgeons, gastroenterologists, medical oncologists, nurses, radiologists, and genetic and nutritional counselors work together closely at all stages to provide seamless, coordinated care. We balance that approach with personalized medicine — not just when it comes to your cancer, but the kind that makes you feel supported throughout your treatment.
City of Hope is one of the few facilities designated a comprehensive cancer center by the National Cancer Institute.
Our developments in the areas of breakthrough cancer drugs, bone marrow transplants and CAR T cell therapy are recognized internationally.
Our leadership in research and innovation continually enhances our ability to provide novel and differentiated approaches to cancer care.
Yi-Jen Chen, M.D., Ph.D., is a radiation oncologist specializing in gastrointestinal cancers, gynecological cancers and esophageal cancers.
Vincent Chung, M.D., is a medical oncologist specializing in pancreatic cancer and gastrointestinal cancers.
Marwan G. Fakih, M.D., is a medical oncologist specializing in gastrointestinal cancers at City of Hope's Duarte and Newport Beach locations.
Lily Lai, M.D., is a colorectal surgeon and associate professor in the Division of Colorectal Surgery, Department of Surgery.
Daneng Li, M.D., is a medical oncologist specializing in geriatric oncology and treating gastrointestinal cancers.
Dean W. Lim, M.D., is a medical oncologist and professor in the Department of Medical Oncology & Therapeutics.
Laleh G. Melstrom, M.D., M.S., specializes in melanoma and pancreatic cancers.
I. Benjamin Paz, M.D., is a nationally renowned surgical oncology surgeon, with expertise in breast cancer, gastrointestinal and rectal cancers, and tumors involving the bone and soft tissues.
Stephen M. Sentovich, M.D., M.B.A., is a colorectal surgeon and a clinical professor in the Division of Colorectal Surgery, Department of Surgery.